SGLT2 Inhibitors in Glomerular Hyperfiltration

NCT04143581 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funds

Conditions

Obesity
Non-diabetic Chronic Kidney Disease

Interventions

DRUG: Empagliflozin 10 MG

Sponsor

Mario Negri Institute for Pharmacological Research

Collaborators

[object Object]